Connection

LOUISE HECKER to Molecular Targeted Therapy

This is a "connection" page, showing publications LOUISE HECKER has written about Molecular Targeted Therapy.
Connection Strength

0.255
  1. Impaired Myofibroblast Dedifferentiation Contributes to Nonresolving Fibrosis in Aging. Am J Respir Cell Mol Biol. 2020 05; 62(5):633-644.
    View in: PubMed
    Score: 0.131
  2. Reversal of persistent fibrosis in aging by targeting Nox4-Nrf2 redox imbalance. Sci Transl Med. 2014 Apr 09; 6(231):231ra47.
    View in: PubMed
    Score: 0.086
  3. Inhibition of mechanosensitive signaling in myofibroblasts ameliorates experimental pulmonary fibrosis. J Clin Invest. 2013 Mar; 123(3):1096-108.
    View in: PubMed
    Score: 0.020
  4. New insights into the pathogenesis and treatment of idiopathic pulmonary fibrosis. Drugs. 2011 May 28; 71(8):981-1001.
    View in: PubMed
    Score: 0.018
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.